Market Research Forecast published a new research publication on "Anti-obesity Drugs Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Anti-obesity Drugs market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in the study are:
Novo Nordisk A/S, GlaxoSmithKline plc, VIVUS LLC, Currax Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, Boehringer Ingelheim International GmbH.
Get Free Exclusive PDF Sample Copy of This Research @ https://marketresearchforecast.com/report/anti-obesity-drugs-market-797/sample-report
Scope of the Report of Anti-obesity Drugs
The Anti-obesity Drugs Marketsize was valued at USD 2.82 USD billion in 2023 and is projected to reach USD 14.30 USD billion by 2032, exhibiting a CAGR of 26.1 % during the forecast period.Anti-obesity drugs are pharmaceutical substances prescribed to treat or manage obesity by assisting weight loss or controlling weight-related ailments. These medications operate through different mechanisms, like: suppression of appetite, reduced fat absorption and modulation of hormones or neurotransmitters connected to metabolism and satiety. Appetite suppressants, e.g. phentermine, lipase inhibitors like orlistat, and combination drugs such as phentermine/topiramate are the ones most commonly used as anti-obesity drugs.
The titled segments and sub-section of the market are illuminated below:
by Type (Prescription Drugs and OTC Drugs), by Distribution Channel (Hospital Pharmacy and Retail and Online Pharmacy)
Market Drivers:
Government initiatives to combat obesity
Technological advancements in drug delivery systems
Changing lifestyle and dietary patterns
Market Trends:
Increasing prevalence of obesity and overweight worldwide
Growing awareness about the health risks associated with obesity
Rising demand for non-surgical weight loss options
Challenges:
Side effects associated with anti-obesity drugs
High cost of anti-obesity drugs
Slow reimbursement process for anti-obesity drugs
Lack of awareness about anti-obesity drugs in developing countries
What can be explored with the Anti-obesity Drugs Market Study?
• Gain Market Understanding
• Identify Growth Opportunities
• Analyse and Measure the Global Anti-obesity Drugs Market by Identifying Investment across various Industry Verticals
• Understand the Trends that will drive Future Changes in Anti-obesity Drugs
• Understand the Competitive Scenarios
- Track Right Markets
- Identify the Right Verticals
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Have Any Questions Regarding Global Anti-obesity Drugs Market Report, Ask Our Experts@ https://marketresearchforecast.com/report/anti-obesity-drugs-market-797/enquiry-before-buy
Strategic Points Covered in Table of Content of Global Anti-obesity Drugs Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Anti-obesity Drugs market
Chapter 2: Exclusive Summary – the basic information of the Anti-obesity Drugs Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Anti-obesity Drugs
Chapter 4: Presenting the Anti-obesity Drugs Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2019-2023
Chapter 6: Evaluating the leading manufacturers of the Anti-obesity Drugs market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2024-2032)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
finally, Anti-obesity Drugs Market is a valuable source of guidance for individuals and companies.
Read Detailed Index of full Research Study at @ https://marketresearchforecast.com/reports/anti-obesity-drugs-market-797
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.
Contact US:
Craig Francis (PR & Marketing Manager)
Market Research Forecast
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: (+1 201 565 3262, +44 161 818 8166)
[email protected]
